La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Coloplast Résultats passés
Passé contrôle des critères 2/6
Coloplast a connu une croissance annuelle moyenne de ses bénéfices de 4.9%, tandis que le secteur Medical Equipment a vu ses bénéfices augmenter de en hausse à 10.4% par an. Les revenus ont augmenté de en hausse à un taux moyen de 8.3% par an. Le rendement des capitaux propres de Coloplast est 30.6% et ses marges nettes sont de 19.5%.
Informations clés
4.8%
Taux de croissance des bénéfices
4.2%
Taux de croissance du BPA
Medical Equipment Croissance de l'industrie | -1.7% |
Taux de croissance des recettes | 8.6% |
Rendement des fonds propres | 30.1% |
Marge nette | 18.9% |
Prochaine mise à jour des résultats | 05 Nov 2024 |
Mises à jour récentes des performances passées
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues
Nov 16Recent updates
Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price
Jul 17These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jun 29Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00
May 10Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Apr 26There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price
Apr 08Is Coloplast (CPH:COLO B) A Risky Investment?
Mar 21Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Jan 09Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings
Dec 22These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 04Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues
Nov 16A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Sep 30Is Coloplast (CPH:COLO B) A Risky Investment?
Jun 28Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price
Jun 10Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Mar 22Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 01These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 14Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 26Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being
Nov 25Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 11With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case
Oct 25Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)
Aug 26These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jul 27Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching
Jul 12Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?
May 23Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00
May 08Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly
Apr 13Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock
Mar 29Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate
Feb 12Coloplast (CPH:COLO B) Could Easily Take On More Debt
Jan 12Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?
Dec 28Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All
Nov 25A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Oct 31Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly
Oct 02Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?
Sep 16Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?
Aug 02Ventilation des recettes et des dépenses
Comment Coloplast gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | D épenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 26,303 | 4,967 | 9,675 | 925 |
31 Mar 24 | 25,526 | 4,965 | 9,252 | 901 |
31 Dec 23 | 25,001 | 4,868 | 8,934 | 889 |
30 Sep 23 | 24,500 | 4,783 | 8,632 | 872 |
30 Jun 23 | 24,333 | 4,784 | 8,581 | 858 |
31 Mar 23 | 24,074 | 4,801 | 8,550 | 864 |
31 Dec 22 | 23,515 | 4,626 | 8,272 | 877 |
30 Sep 22 | 22,579 | 4,706 | 7,800 | 866 |
30 Jun 22 | 21,620 | 4,781 | 7,336 | 856 |
31 Mar 22 | 20,606 | 4,746 | 6,828 | 819 |
31 Dec 21 | 19,857 | 4,896 | 6,446 | 774 |
30 Sep 21 | 19,426 | 4,825 | 6,249 | 755 |
30 Jun 21 | 18,916 | 4,561 | 6,098 | 723 |
31 Mar 21 | 18,500 | 4,304 | 5,938 | 720 |
31 Dec 20 | 18,570 | 4,241 | 5,993 | 725 |
30 Sep 20 | 18,544 | 4,197 | 6,086 | 708 |
30 Jun 20 | 18,572 | 3,949 | 6,113 | 698 |
31 Mar 20 | 18,752 | 4,020 | 6,199 | 691 |
31 Dec 19 | 18,330 | 3,974 | 6,118 | 680 |
30 Sep 19 | 17,939 | 3,873 | 5,970 | 692 |
30 Jun 19 | 17,555 | 4,119 | 5,753 | 686 |
31 Mar 19 | 17,181 | 3,999 | 5,626 | 671 |
31 Dec 18 | 16,815 | 3,896 | 5,488 | 663 |
30 Sep 18 | 16,449 | 3,845 | 5,375 | 640 |
30 Jun 18 | 16,195 | 3,816 | 5,315 | 619 |
31 Mar 18 | 15,882 | 3,778 | 5,211 | 605 |
31 Dec 17 | 15,728 | 3,791 | 5,104 | 594 |
30 Sep 17 | 15,528 | 3,797 | 4,994 | 574 |
30 Jun 17 | 15,287 | 3,211 | 4,880 | 565 |
31 Mar 17 | 15,061 | 3,279 | 4,785 | 551 |
31 Dec 16 | 14,780 | 3,264 | 4,731 | 521 |
30 Sep 16 | 14,681 | 3,143 | 4,693 | 509 |
30 Jun 16 | 14,563 | 1,297 | 4,690 | 494 |
31 Mar 16 | 14,417 | 1,028 | 4,627 | 477 |
31 Dec 15 | 14,264 | 927 | 4,583 | 458 |
30 Sep 15 | 13,909 | 899 | 4,488 | 442 |
30 Jun 15 | 13,502 | 3,162 | 4,343 | 437 |
31 Mar 15 | 13,096 | 3,241 | 4,220 | 418 |
31 Dec 14 | 12,666 | 2,407 | 4,088 | 406 |
30 Sep 14 | 12,428 | 2,390 | 4,002 | 390 |
30 Jun 14 | 12,184 | 2,298 | 3,959 | 375 |
31 Mar 14 | 12,008 | 2,220 | 3,944 | 370 |
31 Dec 13 | 11,833 | 2,874 | 3,889 | 382 |
30 Sep 13 | 11,635 | 2,711 | 3,854 | 380 |
Des revenus de qualité: COLO B a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de COLO B (19.5%) sont inférieures à celles de l'année dernière (19.9%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de COLO B ont augmenté de 4.9% par an au cours des 5 dernières années.
Accélération de la croissance: La croissance des bénéfices de COLO B au cours de l'année écoulée ( 3.4% ) est inférieure à sa moyenne sur 5 ans ( 4.9% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices COLO B au cours de l'année écoulée ( 3.4% ) n'a pas surpassé celle du secteur Medical Equipment 20%.
Rendement des fonds propres
ROE élevé: Bien que le retour sur capitaux propres ( 30.65% ) de COLO B soit élevé, cette mesure est faussée en raison de son niveau d'endettement élevé.